Latest / Diabetes Connections | Type 1 Diabetes
GLP-1s for Type 1 Diabetes: Are We There Yet? With Dr. Cecilia Low Wang
One of the sure-thing top stories of 2026 will be GLP1s, but will we see more studies and even approval for treating type 1 with these medications?
We're talking about Ozempic, Mounjaro and the next versions like Retatrutide - that are just around the corner. I'm talking to Dr. Cecelia Lo Wong, a diabetologist at the University of Colorado whose been on the front lines of this conversation for years, including serving on FDA advisory committees.
This is a wide ranging interview - we also talk about the growing needs of older adults with type 1 diabetes, how kidney and cardiovascular risk…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.